Comment on Breakthrough drug trial saw cancer vanish in every patient (2022)
flappy@lemm.ee 8 months ago
The paper described the results of 12 patients with rectal cancer, all of whom saw their cancer vanish after treatment with dostarlimab.
Huuuuge sample size.
Mikufan@ani.social 8 months ago
For such a cancer drug that’s actually enough. These drugs are extremely specialized for their respective cancers, basically, if it works in 12 people it’s likely to work in 99,9% of patients.